ASHISH JAIN: Open Payments
NPI 1245226331 · CROWN POINT, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 15 payments from 9 companies in 2025. Trend: 2023 $362 · 2024 $849 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $64 |
| Janssen Pharmaceuticals, Inc | 2 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Lundbeck LLC | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $23 |
| Corium, LLC | 3 | $22 |
| Tris Pharma Inc | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: COBENFY, CAPLYTA, SPRAVATO, Auvelity, INVEGA SUSTENNA, VRAYLAR, Azstarys, Dyanavel XR.
Industry payments across IN — which companies pay providers there.
